GeneDx Holdings Corp. Class A
(NASDAQ: WGS)

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

98.160 -

+2.870 (+3.01%)
Range 93.530 - 98.630   (5.45%)
Open 94.000
Previous Close 95.290
Bid Price 96.500
Bid Volume 30
Ask Price 98.870
Ask Volume 5
Volume 554,280
Value 46,004,785
Remark -
Delayed prices. Updated at 30 Jan 2026 06:10.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis